Avanos Medical (AVNS) Long-Term Deferred Tax (2014 - 2026)

Avanos Medical's Long-Term Deferred Tax history runs 13 years deep, the most recent figure standing at $33.0 million for Q1 2026.

• In Q1 2026, Long-Term Deferred Tax rose 32.0% year-over-year to $33.0 million; the TTM figure through Mar 2026 stood at $33.0 million (up 32.0% YoY), while the FY2025 annual figure was $33.1 million, up 32.93% from the prior year.
• Long-Term Deferred Tax came in at $33.0 million for Q1 2026 at Avanos Medical, roughly flat from $33.1 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $33.1 million in Q4 2025 to a low of $4.3 million in Q3 2023.
• A 5-year average of $14.3 million and a median of $10.9 million in 2022 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax tumbled 82.07% in 2022 and soared 301.59% in 2025, its largest moves.
• Avanos Medical's Long-Term Deferred Tax stood at $4.6 million in 2022, then surged by 41.3% to $6.5 million in 2023, then jumped by 283.08% to $24.9 million in 2024, then jumped by 32.93% to $33.1 million in 2025, then retreated by 0.3% to $33.0 million in 2026.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $33.0 million, $33.1 million, and $25.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison